Serum Uric Acid Levels and Endothelial Dysfunction in Patients with Autosomal Dominant Polycystic Kidney Disease

Kocyigit I., Yılmaz M. I., Örsçelik O., SİPAHİOĞLU M. H., ÜNAL A., EROĞLU E., ...Daha Fazla

NEPHRON CLINICAL PRACTICE, cilt.123, ss.157-164, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 123
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1159/000353730
  • Dergi Adı: NEPHRON CLINICAL PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.157-164
  • Erciyes Üniversitesi Adresli: Evet

Özet

Background/Aims: Patients with autosomal dominant polycystic kidney disease (ADPKD) exhibit endothelial dysfunction (ED) despite normal levels of renal function. Hyperuricemia occurs in these patients and has been postulated to affect ED through the generation of oxidative stress. We therefore investigated the prevalence of ED and its association with serum uric acid levels in early-stage ADPKD. Methods: A cross-sectional design was used for the assessment of prevalent patients with early-stage (normal renal function) ADPKD (n = 91) from two academic medical centers. ED was assessed using ischemia-induced forearm flow-mediated vasodilation (FMD). Serum uric acid levels were evaluated using an Olympus AU2700 autoanalyzer. Results: ADPKD patients with higher serum uric acid levels had a higher asymmetric dimethylarginine (ADMA) level (1.19 +/- 0.2 vs. 1.47 +/- 0.3, p < 0.001) and lower FMD rates (8.1 +/- 1.3 vs. 6.8 +/- 0.7, p < 0.001). In multiple regression analysis for predictors of cohort FMD, uric acid (beta = -0.32, p < 0.001), ADMA (beta = -0.36, p < 0.001), high-sensitivity C reactive protein (CRP; beta = -0.32, p < 0.001) and estimated glomerular filtration rate (eGFR; beta = 0.33, p < 0.001) all predicted FMD. Conclusions: In early-stage ADPKD patients, uric acid levels, serum ADMA and eGFR all independently predict ED in a similar manner. Future studies are needed to investigate the causes of elevated serum uric acid, ADMA and CRP in these patients. Copyright (C) 2013 S. Karger AG, Basel